Cargando…
Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England
Background: Clinicians mediate access to closed-loop technology for people with diabetes. Consequently, their attitudes regarding appropriate levels of closed-loop usage will play a key role in future adoption processes. This study aimed to explore clinician attitudes toward future mainstream closed...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196368/ https://www.ncbi.nlm.nih.gov/pubmed/31913061 http://dx.doi.org/10.1089/dia.2019.0380 |
_version_ | 1783528710484262912 |
---|---|
author | Farrington, Conor Hovorka, Roman Murphy, Helen R. |
author_facet | Farrington, Conor Hovorka, Roman Murphy, Helen R. |
author_sort | Farrington, Conor |
collection | PubMed |
description | Background: Clinicians mediate access to closed-loop technology for people with diabetes. Consequently, their attitudes regarding appropriate levels of closed-loop usage will play a key role in future adoption processes. This study aimed to explore clinician attitudes toward future mainstream closed-loop usage in England. Materials and Methods: We conducted 36 semistructured interviews with clinicians from a range of professional backgrounds working in outpatient clinics in England. Interview topics included clinicians' views on future pathways for closed-loop use and attitudes toward the predictability of users' technology experiences, a key factor in eligibility decision making. We analyzed transcripts using thematic and framework approaches. Results: Clinicians exhibited a range of opinions regarding future eligibility for closed-loop technology. We identified three key strands of clinician opinion, envisaging (1) tighter access for closed loop (n = 10), citing funding challenges and issues arising from user overconfidence or negative technology attitudes; (2) similar access to closed loop as for current diabetes technologies (n = 15), on the grounds that future funding and access pathways will be similar to current arrangements; and (3) wider access for closed-loop technologies (n = 9), given the potential for significant and widespread benefits arising from closed-loop usage, including downstream cost savings alongside improved glycemic control. Conclusions: Clinicians expressed a range of opinions encompassing continuity with current diabetes technologies, while others envisaged either tighter or more liberal access for closed-loop systems. To optimize technology adoption and equitable uptake, future implementation pathways should consider clinician attitudes toward technology use and access. |
format | Online Article Text |
id | pubmed-7196368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-71963682020-05-04 Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England Farrington, Conor Hovorka, Roman Murphy, Helen R. Diabetes Technol Ther Original Articles Background: Clinicians mediate access to closed-loop technology for people with diabetes. Consequently, their attitudes regarding appropriate levels of closed-loop usage will play a key role in future adoption processes. This study aimed to explore clinician attitudes toward future mainstream closed-loop usage in England. Materials and Methods: We conducted 36 semistructured interviews with clinicians from a range of professional backgrounds working in outpatient clinics in England. Interview topics included clinicians' views on future pathways for closed-loop use and attitudes toward the predictability of users' technology experiences, a key factor in eligibility decision making. We analyzed transcripts using thematic and framework approaches. Results: Clinicians exhibited a range of opinions regarding future eligibility for closed-loop technology. We identified three key strands of clinician opinion, envisaging (1) tighter access for closed loop (n = 10), citing funding challenges and issues arising from user overconfidence or negative technology attitudes; (2) similar access to closed loop as for current diabetes technologies (n = 15), on the grounds that future funding and access pathways will be similar to current arrangements; and (3) wider access for closed-loop technologies (n = 9), given the potential for significant and widespread benefits arising from closed-loop usage, including downstream cost savings alongside improved glycemic control. Conclusions: Clinicians expressed a range of opinions encompassing continuity with current diabetes technologies, while others envisaged either tighter or more liberal access for closed-loop systems. To optimize technology adoption and equitable uptake, future implementation pathways should consider clinician attitudes toward technology use and access. Mary Ann Liebert, Inc., publishers 2020-05-01 2020-04-27 /pmc/articles/PMC7196368/ /pubmed/31913061 http://dx.doi.org/10.1089/dia.2019.0380 Text en © Conor Farrington, et al., 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Original Articles Farrington, Conor Hovorka, Roman Murphy, Helen R. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England |
title | Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England |
title_full | Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England |
title_fullStr | Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England |
title_full_unstemmed | Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England |
title_short | Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England |
title_sort | who should access closed-loop technology? a qualitative study of clinician attitudes in england |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196368/ https://www.ncbi.nlm.nih.gov/pubmed/31913061 http://dx.doi.org/10.1089/dia.2019.0380 |
work_keys_str_mv | AT farringtonconor whoshouldaccessclosedlooptechnologyaqualitativestudyofclinicianattitudesinengland AT hovorkaroman whoshouldaccessclosedlooptechnologyaqualitativestudyofclinicianattitudesinengland AT murphyhelenr whoshouldaccessclosedlooptechnologyaqualitativestudyofclinicianattitudesinengland |